Allowance 发表于 2025-3-27 00:37:16

http://reply.papertrans.cn/16/1587/158648/158648_31.png

POWER 发表于 2025-3-27 04:23:50

https://doi.org/10.1007/978-1-4615-4849-2el, GP IIb-IIIa antagonists) and “complicated” relationships with aspirin ticagrelor). In this chapter, we present the genetic and pharmacological evidence that supports the development and expectations associated with novel antiplatelet strategies directed at intrasignaling pathways.

Glycogen 发表于 2025-3-27 06:21:06

Platelet Signalingplatelet activation, after which the final section briefly considers individual variations in platelet reactivity and the role of platelet signaling in the innate immune response and embryonic development.

ascetic 发表于 2025-3-27 12:53:05

http://reply.papertrans.cn/16/1587/158648/158648_34.png

GIDDY 发表于 2025-3-27 17:37:09

Intracellular Signaling as a Potential Target for Antiplatelet Therapyel, GP IIb-IIIa antagonists) and “complicated” relationships with aspirin ticagrelor). In this chapter, we present the genetic and pharmacological evidence that supports the development and expectations associated with novel antiplatelet strategies directed at intrasignaling pathways.

OMIT 发表于 2025-3-27 19:34:49

http://reply.papertrans.cn/16/1587/158648/158648_36.png

懒惰民族 发表于 2025-3-28 00:19:23

Electromagnetic Response of Material MediaWell-understood functions for “traditional” platelet receptors are described, but “newer” receptors are equally discussed. Receptors are described biochemically (structure, ligand(s), protein partners, and function) and whenever possible, their clinical importance (mutations, polymorphisms, syndrome) are highlighted.

抛媚眼 发表于 2025-3-28 02:19:15

http://reply.papertrans.cn/16/1587/158648/158648_38.png

节约 发表于 2025-3-28 08:28:58

http://reply.papertrans.cn/16/1587/158648/158648_39.png

单调女 发表于 2025-3-28 11:04:23

http://reply.papertrans.cn/16/1587/158648/158648_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: Antiplatelet Agents; Paolo Gresele,Gustav V. R Born,Clive P. Page Book 2012 Springer-Verlag Berlin Heidelberg 2012 Antithrombotic Therapy.